OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $733 | +19.4% | 233,582 | +96.4% | 0.06% | +3.3% |
| Q2 2023 | $614 | -99.9% | 118,953 | -7.1% | 0.06% | -20.8% |
| Q2 2022 | $514,000 | +80.4% | 127,978 | +122.1% | 0.08% | +102.6% |
| Q1 2022 | $285,000 | +738.2% | 57,620 | +413.5% | 0.04% | +660.0% |
| Q3 2019 | $34,000 | -66.7% | 11,222 | -28.1% | 0.01% | 0.0% |
| Q1 2018 | $102,000 | -60.9% | 15,600 | +25.7% | 0.01% | -50.0% |
| Q2 2015 | $261,000 | – | 12,412 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |